109 related articles for article (PubMed ID: 3997199)
1. Infiltration density of HNK 1 positive cells in non-Hodgkin's lymphomas depends on histologic subtype: an in situ morphometric analysis.
Gattringer C; Radaszkiewicz T; Pfaller W; Huber H
Immunobiology; 1985 Apr; 169(3):280-91. PubMed ID: 3997199
[TBL] [Abstract][Full Text] [Related]
2. [Infiltration pattern of immunocompetent lymphocytes in the tissue of malignant non-Hodgkin's lymphoma: relationship to histological and clinical parameters].
Gattringer C; Radaszkiewicz T; Greil R; Pfaller W; Huber H
Wien Klin Wochenschr; 1985 Mar; 97(5):258-63. PubMed ID: 3873140
[TBL] [Abstract][Full Text] [Related]
3. [Host reaction in non-Hodgkin's lymphomas: tumor infiltration with monocytes/macrophages].
Lechleitner M; Gattringer C; Radaszkiewicz T; Pfaller W; Huber H
Wien Klin Wochenschr; 1985 Mar; 97(5):255-8. PubMed ID: 3887765
[TBL] [Abstract][Full Text] [Related]
4. Imbalance of helper and suppressor T lymphocytes in malignant non-Hodgkin lymphomas: an in situ morphometric analysis.
Gattringer C; Huber H; Radaszkiewicz T; Pfaller W; Braunsteiner H
Int J Cancer; 1984 Jun; 33(6):751-7. PubMed ID: 6234239
[TBL] [Abstract][Full Text] [Related]
5. Immunopathology of non-Hodgkin lymphomas.
Huber H; Gattringer C; Knapp W; Stein H
Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
[TBL] [Abstract][Full Text] [Related]
6. Distribution of HNK-1+ cells in malignant lymphomas.
Mori S; Yamaguchi K; Morita H; Mohri N
Acta Pathol Jpn; 1985 Mar; 35(2):339-50. PubMed ID: 3895822
[TBL] [Abstract][Full Text] [Related]
7. HNK-1+ cells in non-Hodgkin's lymphoma: lack of relation with transferrin receptor expression on malignant cells.
Schuurman HJ; Kluin PM; de Gast GC; Kater L
Br J Cancer; 1985 Feb; 51(2):171-7. PubMed ID: 2981539
[TBL] [Abstract][Full Text] [Related]
8. Macrophage infiltration in non-Hodgkin's lymphomas: a quantitative in situ study.
Lechleitner M; Gattringer C; Gastl G; Radaskiewicz T; Pfaller W; Schmalzl F; Huber H
Immunobiology; 1986 Jul; 171(4-5):381-7. PubMed ID: 3744419
[TBL] [Abstract][Full Text] [Related]
9. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
Stein H
Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
[TBL] [Abstract][Full Text] [Related]
10. Low grade malignant non-Hodgkin's lymphomas and peripheral pleomorphic T-cell lymphomas in childhood--a BFM study group report.
Bucsky P; Feller AC; Reiter A; Beck J; Bertram U; Eschenbach C; Gerein V; Lakomek M; Stollmann B; Tausch W
Klin Padiatr; 1990; 202(4):258-61. PubMed ID: 2203939
[TBL] [Abstract][Full Text] [Related]
11. [Retrospective analysis of the clinical relevance of the Kiel classification of malignant non-Hodgkin's lymphomas (author's transl)].
Brittinger G; Bartels H; Bremer K; Burger A; Dühmke E; Gunzer U; König E; Stacher A; Stein H; Theml H; Waldner R
Strahlentherapie; 1977 Apr; 153(4):222-8. PubMed ID: 324031
[TBL] [Abstract][Full Text] [Related]
12. [Non-Hodgkin's lymphomas of low-grade malignancy with particular reference to the lymphocytic lymphomas of B-cell origin (author's transl)].
Wessel H
Arch Geschwulstforsch; 1979; 49(8):635-47. PubMed ID: 317425
[TBL] [Abstract][Full Text] [Related]
13. [Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms].
Huber H; Gattringer C; Thaler J; Peschel C
Behring Inst Mitt; 1985 Dec; (78):83-117. PubMed ID: 3914283
[TBL] [Abstract][Full Text] [Related]
14. Growth fraction of tumour cells and infiltration density with natural killer-like (HNK1+) cells in non-Hodgkin lymphomas.
Greil R; Gattringer C; Knapp W; Huber H
Br J Haematol; 1986 Feb; 62(2):293-300. PubMed ID: 3004554
[TBL] [Abstract][Full Text] [Related]
15. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas.
Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G
Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942
[TBL] [Abstract][Full Text] [Related]
16. Cell-surface-marker phenotyping in patients with leukemic non-Hodgkin lymphomas (NHL) of low and intermediate malignancy.
Herrmann F; Wirthmüller R
Immunobiology; 1982 Oct; 163(1):77-94. PubMed ID: 7173978
[TBL] [Abstract][Full Text] [Related]
17. HNK-1 monoclonal antibody (Leu-7) in the identification of abnormal expansions of large granular lymphocytes.
Pandolfi F; Semenzato G; de Rossi G; Quinti I; Guglielmi C; Pezzutto A; Lopez M; Tonietti G; Fontana L; Abo T; Aiuti F
Clin Exp Immunol; 1983 Jun; 52(3):641-7. PubMed ID: 6603302
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of proliferative and apoptotic fractions in low grade follicle center cell-derived non-Hodgkin's lymphomas.
Czader M; Mazur J; Pettersson M; Liliemark J; Strömberg M; Christensson B; Tribukait B; Auer G; Ost A; Porwit A
Cancer; 1996 Mar; 77(6):1180-8. PubMed ID: 8635141
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin's lymphoma phenotyping: problems in the use of heterologous and monoclonal antibodies.
Barcos M; Minowada J; Minato K; Pollard C; Cancino M; Han T; Henderson E; Ozer H
Leuk Res; 1983; 7(4):523-37. PubMed ID: 6604849
[TBL] [Abstract][Full Text] [Related]
20. Cytomorphometric characterization of NHL(non-Hodgkin's lymphomas) of low and high grade malignancy.
Haroske G; Ehlers U; Ehlers HM; Kunze KD
Arch Geschwulstforsch; 1984; 54(1):41-51. PubMed ID: 6367693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
